Clinical Trial Update: Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating the efficacy and safety of AN2898 and AN2728 topical ointments for mild-to-moderate atopic dermatitis. Results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AN2728
• AN2898

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2017-03-07